Integrated Electroosmotic Perfusion of Tissue with Online Microfluidic Analysis to Track the Metabolism of Cystamine, Pantethine, and Coenzyme A
- 22 November 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 85 (24) , 12020-12027
Abstract
We have developed an approach that integrates electroosmotic perfusion of tissue with a substrate-containing solution and online microfluidic analysis of products, in this case thiols. Using this approach we have tracked the metabolism of cystamine, pantethine and CoA in the extracellular space of organotypic hippocampal slice cultures (OHSCs). Currently, little is known about coenzyme A (CoA) biodegradation and even less is known about the regulation and kinetic characteristics for this sequential multienzyme reaction. We found that the steady state percentage yields of cysteamine from cystamine and pantethine during the transit through OHSCs were 91% ± 4% (SEM) and 0.01% - 0.03%, respectively. The large difference in the yields of cysteamine can be used to explain the drugs’ different toxicities and clinical effectiveness against cystinosis. The kinetic parameters of the enzyme reaction catalyzed by the ectoenzyme pantetheinase are KM,C/α = 4.4 ± 1.1 mM and Vmax,C = 29 ± 3 nM/s, where α is the percentage yield of pantethine to pantetheine through disulfide exchange. We estimate that the percentage yield of pantethine to pantetheine through disulfide exchange is approximately 0.5%. Based on the formation rate of cysteamine in the OHSCs, we obtained the overall apparent Michaelis constant and maximum reaction rate for sequential, extracellular CoA degradation in an in situ environment, which are K′M = 16 ± 4 μM, V′max = 7.1 ± 0.5 nM/s. Kinetic parameters obtained in situ, although difficult to measure, are better representations of the biochemical flux in the living organism than those from isolated enzymes in vitro.Keywords
This publication has 45 references indexed in Scilit:
- Heptahelical protein PQLC2 is a lysosomal cationic amino acid exporter underlying the action of cysteamine in cystinosis therapyProceedings of the National Academy of Sciences, 2012
- Hippocampal Neurogenesis, Cognitive Deficits and Affective Disorder in Huntington's DiseaseNeural Plasticity, 2012
- Pantethine Rescues Phosphopantothenoylcysteine Synthetase and Phosphopantothenoylcysteine Decarboxylase Deficiency in Escherichia coli but Not in Pseudomonas aeruginosaJournal of Bacteriology, 2011
- Integration of a Precolumn Fluorogenic Reaction, Separation, and Detection of Reduced GlutathioneAnalytical Chemistry, 2010
- Minimizing Tissue Damage in Electroosmotic SamplingAnalytical Chemistry, 2010
- Measurement of sulfur-containing compounds involved in the metabolism and transport of cysteamine and cystamine. Regional differences in cerebral metabolismJournal of Chromatography B, 2009
- Cystamine prevents haloperidol‐induced decrease of BDNF/TrkB signaling in mouse frontal cortexJournal of Neurochemistry, 2008
- Protection against cerebral malaria by the low-molecular-weight thiol pantethineProceedings of the National Academy of Sciences, 2008
- Glutathione Pathways in the BrainBiological Chemistry, 2003
- Plasma Membrane Repair Is Mediated by Ca2+-Regulated Exocytosis of LysosomesCell, 2001